169 related articles for article (PubMed ID: 12528387)
1. Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic.
Hudecková H; Straka S; Szilágyiová M; Avdicová M; Rusnáková S
Cent Eur J Public Health; 2002 Dec; 10(4):146-8. PubMed ID: 12528387
[TBL] [Abstract][Full Text] [Related]
2. [Cost-benefit analysis of vaccinal prevention of hepatitis B policy].
Kerleau M; Flori YA; Nalpas B; Lanoé JL; Berthelot P; Fardeau-Gautier M
Rev Epidemiol Sante Publique; 1995; 43(1):48-60. PubMed ID: 7892516
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
4. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
5. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
Vimolket T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological features and economic evaluation of a potential chickenpox vaccination strategy in Slovak Republic.
Hudecková H; Straka S; Rusnáková S
Cent Eur J Public Health; 2000 Nov; 8(4):227-8. PubMed ID: 11125976
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness analysis of different alternatives of universal vaccination against hepatitis B in the region of Murcia].
Guillén Grima F; Espín Ríos MI
Med Clin (Barc); 1995 Feb; 104(4):130-6. PubMed ID: 7898156
[TBL] [Abstract][Full Text] [Related]
9. [[Health and economic benefits of mandatory regular vaccination in the Slovak Republic. III. Diphtheria, tetanus and pertussis] ].
Hudecková H; Straka S; Szilágyiová M; Rusnáková S
Epidemiol Mikrobiol Imunol; 2000 Nov; 49(4):153-7. PubMed ID: 11188762
[TBL] [Abstract][Full Text] [Related]
10. [Health and economic benefits of mandatory regular vaccination in the Slovak Republic. II. Poliomyelitis].
Hudecková H; Straka S
Epidemiol Mikrobiol Imunol; 2000 Apr; 49(2):59-63. PubMed ID: 10838777
[TBL] [Abstract][Full Text] [Related]
11. Cost-benefit analysis of hepatitis B vaccination.
Jönsson B
Postgrad Med J; 1987; 63 Suppl 2():27-32. PubMed ID: 3120169
[TBL] [Abstract][Full Text] [Related]
12. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
13. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
Jacobs RJ; Rosenthal P; Meyerhoff AS
Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
[TBL] [Abstract][Full Text] [Related]
15. [Health and economic benefits of mandatory regular vaccination in Slovakia. IV. Measles, rubella and mumps].
Hudecková H; Straka S; Avdicová M; Rusnáková S
Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):31-5. PubMed ID: 11233671
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
Rein DB; Weinbaum CM
Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
[TBL] [Abstract][Full Text] [Related]
17. [A cost-effectiveness analysis of vaccination against the hepatitis B virus].
Antoñanzas F; Forcén T; Garuz R
Med Clin (Barc); 1992 Jun; 99(2):41-6. PubMed ID: 1630178
[TBL] [Abstract][Full Text] [Related]
18. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
Ginsberg GM; Berger S; Shouval D
Bull World Health Organ; 1992; 70(6):757-67. PubMed ID: 1486673
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
20. [A method for evaluating the hepatitis B vaccination program].
Corrao G; Calleri M; Carle F; Russo R; Favilli S
Ann Ist Super Sanita; 1989; 25(2):337-43. PubMed ID: 2531564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
